| Enhanced, EHR-facilitated Cancer Symptom Control Pragmatic Clinical Trial (NCT03892967) | Mayo Clinic | 2019-03-28 |
| Hu8F4 in Treating Patients With Advanced Hematologic Malignancies (NCT02530034) | M.D. Anderson Cancer Center | 2019-01-31 |
| Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant (NCT03531281) | City of Hope Medical Center | 2018-12-30 |
| Fecal Microbiota Transplantation for Steroid Resistant/Dependent Acute GI GVHD (NCT03812705) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2018-12-13 |
| Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer (NCT03579446) | M.D. Anderson Cancer Center | 2018-11-29 |
| 2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies (NCT03712878) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2018-09-19 |
| Risk of Chemotherapy Toxicity in Older Patients With Blood Cancer or Non-small Cell Lung Cancer (NCT05106374) | Ohio State University Comprehensive Cancer Center | 2018-09-04 |
| CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant (NCT03560752) | City of Hope Medical Center | 2018-08-20 |
| Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease (NCT03425526) | M.D. Anderson Cancer Center | 2018-03-15 |
| Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy (NCT03080883) | Academic and Community Cancer Research United | 2017-07-14 |
| Atezolizumab in Treating Patients With Cancer Following Adoptive Cell Transfer (NCT02862275) | National Cancer Institute (NCI) | 2017-05-24 |
| Ropidoxuridine and Whole Brain Radiation Therapy in Treating Patients With Brain Metastases (NCT02993146) | National Cancer Institute (NCI) | 2017-05-08 |
| Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers (NCT03207854) | University of Southern California | 2017-04-12 |
| Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I) (NCT04439227) | National Cancer Institute (NCI) | 2017-03-24 |
| A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing Toxicity (NCT03032783) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2017-01-31 |
| Comprehensive Nutritional Geriatric Assessments in Identifying Malnutrition in Older Cancer Participants (NCT03035604) | M.D. Anderson Cancer Center | 2017-01-24 |
| Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology (NCT02847130) | Children's Oncology Group | 2016-11-21 |
| Preliminary Testing of the MD Anderson Symptom Inventory (Adolescent Version) (NCT02515383) | M.D. Anderson Cancer Center | 2016-11-09 |
| Exercise Prehab in Older Adults With Hematologic Malignancies (NCT02791737) | Ohio State University Comprehensive Cancer Center | 2016-08-15 |
| Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant (NCT02861417) | M.D. Anderson Cancer Center | 2016-08-05 |
| Testing Nivolumab as a Potential Targeted Treatment in Cancers With Mismatch Repair Deficiency (MATCH-Subprotocol Z1D) (NCT04439214) | National Cancer Institute (NCI) | 2016-05-31 |
| Testing Palbociclib (PD-0332991) as a Potential Targeted Treatment in Cancers With CCND1, 2, 3 Amplification (MATCH-Subprotocol Z1B) (NCT04439201) | National Cancer Institute (NCI) | 2016-05-31 |
| Testing AZD5363 as a Potential Targeted Treatment in Cancers With AKT Genetic Changes (MATCH-Subprotocol Y) (NCT04439123) | National Cancer Institute (NCI) | 2016-05-31 |
| Testing Binimetinib as a Potential Targeted Treatment in Cancers With NRAS Genetic Changes (MATCH-Subprotocol Z1A) (NCT04439344) | National Cancer Institute (NCI) | 2016-05-31 |
| Testing AZD4547 as a Potential Targeted Treatment in Cancers With FGFR Genetic Changes (MATCH-Subprotocol W) (NCT04439240) | National Cancer Institute (NCI) | 2016-05-31 |
| Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy (NCT02710253) | M.D. Anderson Cancer Center | 2016-05-25 |
| Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Genetic Changes (MATCH-Subprotocol N) (NCT04439149) | National Cancer Institute (NCI) | 2016-05-05 |
| Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors (NCT02717507) | Children's Oncology Group | 2016-04-04 |
| Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Loss of Expression (MATCH-Subprotocol P) (NCT04439188) | National Cancer Institute (NCI) | 2016-03-21 |
| Testing Trametinib as a Potential Targeted Treatment in Cancers With NF1 Genetic Changes (MATCH-Subprotocol S1) (NCT04439318) | National Cancer Institute (NCI) | 2016-02-25 |
| Testing GDC-0032 (Taselisib) as a Potential Targeted Treatment in Cancers With PIK3CA Genetic Changes (MATCH-Subprotocol I) (NCT04439175) | National Cancer Institute (NCI) | 2016-02-25 |
| Evaluation of Satisfaction With Quality of Care on the Palliative Care Unit (NCT02686411) | M.D. Anderson Cancer Center | 2016-02-17 |
| Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E) (NCT06303167) | National Cancer Institute (NCI) | 2016-01-08 |
| Testing Trametinib and Dabrafenib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol H) (NCT04439292) | National Cancer Institute (NCI) | 2016-01-04 |
| Testing VS-6063 (Defactinib) as a Potential Targeted Treatment in Cancers With NF2 Genetic Changes (MATCH-Subprotocol U) (NCT04439331) | National Cancer Institute (NCI) | 2015-11-19 |
| Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure (NCT02464696) | M.D. Anderson Cancer Center | 2015-10-06 |
| Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) (NCT02465060) | National Cancer Institute (NCI) | 2015-08-17 |
| Testing Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B) (NCT04439136) | National Cancer Institute (NCI) | 2015-08-12 |
| Testing Trametinib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol R) (NCT04439279) | National Cancer Institute (NCI) | 2015-08-12 |
| Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol Q) (NCT04439110) | National Cancer Institute (NCI) | 2015-08-12 |
| Testing Crizotinib as a Potential Targeted Treatment in Cancers With ROS1 Genetic Changes (MATCH-Subprotocol G) (NCT04439253) | National Cancer Institute (NCI) | 2015-08-12 |
| Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant (NCT02396134) | City of Hope Medical Center | 2015-05-21 |
| Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection (NCT02210078) | M.D. Anderson Cancer Center | 2015-02-19 |
| Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer (NCT01628029) | M.D. Anderson Cancer Center | 2014-01-15 |
| Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid Malignancies (NCT01919619) | M.D. Anderson Cancer Center | 2013-11-04 |
| Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer (NCT01902173) | National Cancer Institute (NCI) | 2013-10-08 |
| INSPIRE: Internet and Social-media Program With Information and Resources for Long-Term Cancer Survivors Who Underwent Stem Cell Transplant (NCT01602211) | Fred Hutchinson Cancer Center | 2013-05-14 |
| Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant (NCT01503515) | Children's Oncology Group | 2013-03-21 |
| Donor Cord Blood T-Cell Infusion After Stem Cell Transplant in Treating Patients With Relapsed Hematological Malignancies (NCT01630564) | M.D. Anderson Cancer Center | 2013-03-11 |
| CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies (NCT01664910) | M.D. Anderson Cancer Center | 2012-10-29 |
| Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction (NCT01638533) | National Cancer Institute (NCI) | 2012-08-03 |
| New Magnetic Resonance Imaging and Spectroscopy Software in the Improvement of Image Quality (NCT03980535) | M.D. Anderson Cancer Center | 2012-04-16 |
| Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program (NCT01772771) | M.D. Anderson Cancer Center | 2012-03-01 |
| Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant (NCT01251575) | Fred Hutchinson Cancer Center | 2010-12-01 |
| Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant (NCT01231412) | Fred Hutchinson Cancer Center | 2010-11-01 |
| Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer (NCT00968630) | Fred Hutchinson Cancer Center | 2009-12-17 |
| Azacitidine and Oxaliplatin In Treating Patients With Advanced Cancers Relapsed or Refractory to Any Platinum Therapy (NCT01039155) | National Cancer Institute (NCI) | 2009-12-01 |
| Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders (NCT00588991) | National Cancer Institute (NCI) | 2008-02-04 |
| Collection of Outcomes Data for Pregnant Patients With Cancer (NCT00507572) | M.D. Anderson Cancer Center | 2005-12-19 |
| Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy (NCT00991094) | M.D. Anderson Cancer Center | 2005-05-27 |
| Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00075478) | Fred Hutchinson Cancer Center | 2003-10-01 |